These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26482321)

  • 1. Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.
    Walther C; Mayrhofer M; Nilsson J; Hofvander J; Jonson T; Mandahl N; Øra I; Gisselsson D; Mertens F
    Genes Chromosomes Cancer; 2016 Jan; 55(1):3-15. PubMed ID: 26482321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
    Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
    Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
    Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
    Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.
    Gordon T; McManus A; Anderson J; Min T; Swansbury J; Pritchard-Jones K; Shipley J; ;
    Med Pediatr Oncol; 2001 Feb; 36(2):259-67. PubMed ID: 11452933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
    Gil-Benso R; López-Ginés C; Carda C; López-Guerrero JA; Ferrer J; Pellín-Pérez A; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jul; 144(2):125-33. PubMed ID: 12850375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative genomic hybridization: the profile of chromosomal imbalances in rhabdomyosarcoma].
    Li QX; Liu CX; Chun CP; Qi Y; Chang B; Nong WX; Yao ES; Li HA; Li F
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):536-41. PubMed ID: 19094465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
    Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
    Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
    Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
    Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.
    Liu C; Li D; Hu J; Jiang J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
    Int J Clin Exp Pathol; 2014; 7(2):690-8. PubMed ID: 24551291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
    Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.
    Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR
    Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation.
    Yang XL; Zhang SC; Zhang SW; Wang H
    Ann Diagn Pathol; 2012 Apr; 16(2):107-11. PubMed ID: 22197543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
    Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
    Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience.
    Lee DH; Park CJ; Jang S; Cho YU; Seo JJ; Im HJ; Koh KN; Cho KJ; Song JS; Seo EJ
    Ann Lab Med; 2018 Mar; 38(2):132-138. PubMed ID: 29214757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.
    Paulson V; Chandler G; Rakheja D; Galindo RL; Wilson K; Amatruda JF; Cameron S
    Genes Chromosomes Cancer; 2011 Jun; 50(6):397-408. PubMed ID: 21412928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhabdomyosarcoma and extraosseous Ewing's sarcoma].
    Harms D; Leuschner I; Krams M; Pilgrim TB; Treuner J
    Verh Dtsch Ges Pathol; 1998; 82():83-98. PubMed ID: 10095421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.